<SEC-DOCUMENT>0001493152-21-017665.txt : 20210723
<SEC-HEADER>0001493152-21-017665.hdr.sgml : 20210723
<ACCEPTANCE-DATETIME>20210723170104
ACCESSION NUMBER:		0001493152-21-017665
CONFORMED SUBMISSION TYPE:	S-3
PUBLIC DOCUMENT COUNT:		8
FILED AS OF DATE:		20210723
DATE AS OF CHANGE:		20210723

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LifeMD, Inc.
		CENTRAL INDEX KEY:			0000948320
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
		IRS NUMBER:				760238453
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-258143
		FILM NUMBER:		211111515

	BUSINESS ADDRESS:	
		STREET 1:		800 THIRD AVENUE, SUITE 2800
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		(866) 351-5907

	MAIL ADDRESS:	
		STREET 1:		800 THIRD AVENUE, SUITE 2800
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CONVERSION LABS, INC.
		DATE OF NAME CHANGE:	20180622

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Immudyne, Inc.
		DATE OF NAME CHANGE:	20120514

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	IMMUDYNE INC
		DATE OF NAME CHANGE:	19950720
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>forms-3.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>As
filed with the Securities and Exchange Commission on July 23, 2021</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration
No. 333- </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
S-3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OF 1933</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>LIFEMD,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>76-0238453</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction of</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">incorporation
    or organization)</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    Number)</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>800
Third Avenue, Suite 2800</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
York, NY 10022</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(855)
743-6478</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address,
including zip code, and telephone number, including area code, of registrant&rsquo;s principal executive offices)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Justin
Schreiber</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>800
Third Avenue, Suite 2800</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
York, NY 10022</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Telephone:
(855) 743-6478</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name,
address, including zip code, and telephone number, including area code, of agent for service)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Copies
to:</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Joseph
M. Lucosky, Esq.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lawrence
Metelitsa, Esq.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lucosky
Brookman LLP</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>101
Wood Avenue South, 5th Floor</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Iselin,
NJ 08830</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(732)
395-4400</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APPROXIMATE
DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC:</B> From time to time after the effective date of this registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check
the following box. [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following
box. [X]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the
following box and list the Securities Act registration statement number of the earlier effective registration statement for the same
offering. [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective
on filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional
securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting
company, or an emerging growth company. See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer&rdquo;
&ldquo;smaller reporting company&rdquo; and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act. (Check one):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    accelerated filer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated
    filer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[X]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    reporting company</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[X]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    growth company</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CALCULATION
OF REGISTRATION FEE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Title of Each Class of Securities to be Registered</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount of Shares to be Registered (1)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Proposed<BR> Maximum<BR> Offering<BR> Price per<BR> Share (2)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Proposed<BR> Maximum<BR> Aggregate<BR> Offering<BR> Price</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount of<BR> Registration<BR> Fee</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; padding-bottom: 1.5pt">Common Stock, $0.001 par value per share, issuable upon exercise of the Warrants</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; border-bottom: Black 1.5pt solid; text-align: right">1,500,000</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="width: 11%; border-bottom: Black 1.5pt solid; text-align: right">9.22</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="width: 11%; border-bottom: Black 1.5pt solid; text-align: right">13,830,000</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="width: 11%; border-bottom: Black 1.5pt solid; text-align: right">1,508.86</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt">Total</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,500,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">9.22&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">13,830,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,508.86</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
    to Rule 416 under the Securities Act of 1933, as amended, the shares of Common Stock (as defined below) being registered hereunder
    include such indeterminate number of shares of Common Stock as may be issuable with respect to the shares of Common Stock being registered
    hereunder as a result of stock splits, stock dividends or similar transactions.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act. Based on the average
    of the high and low reported trading prices of Common Stock as reported on the Nasdaq Capital Market on July 20, 2021.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    the maximum number of shares of common stock that the Registrant expects could be issuable upon the exercise of the Warrants (as
    defined below), all of which were acquired by the Selling Stockholder.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paid
    herewith.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the
registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective
in accordance with Section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date
as the Commission, acting pursuant to said Section 8(a), may determine.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>The
information in this prospectus is not complete and may be changed. These securities may not be sold until the registration statement
filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell nor does it seek
an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>Subject
to Completion, dated July 23, 2021.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="forms-3_001.jpg" ALT="" STYLE="height: 42px; width: 203px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LIFEMD,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1,500,000
Shares of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus relates to the resale, from time to time, of up to 1,500,000 shares (the &ldquo;Shares&rdquo;) of our common stock, par value
$0.001 per share (&ldquo;Common Stock&rdquo;), underlying the Warrants (as defined herein) held by the selling stockholder identified
in this prospectus under &ldquo;Selling Stockholder&rdquo; (the &ldquo;Offering&rdquo;) pursuant to the June 2021 Financing (as defined
herein). We will receive proceeds from any warrants that are exercised through the payment of the exercise price in cash. The Selling
Stockholder will bear all commissions and discounts, if any, attributable to the sale of the Shares. We will bear all costs, expenses
and fees in connection with the registration of the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
securities may be sold without delivery of this prospectus and the applicable prospectus supplement describing the method and terms of
the offering of such securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INVESTING
IN OUR SECURITIES INVOLVES RISKS. SEE THE &ldquo;RISK FACTORS&rdquo; ON PAGE 6 OF THIS PROSPECTUS AND ANY SIMILAR SECTION CONTAINED
IN THE APPLICABLE PROSPECTUS SUPPLEMENT CONCERNING FACTORS YOU SHOULD CONSIDER BEFORE INVESTING IN OUR SECURITIES.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock is listed on The NASDAQ Capital Market under the symbol &ldquo;LFMD&rdquo;. On July 20, 2021, the last reported sale
price of our Common Stock on The NASDAQ Capital Market was $9.22 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investing
in our securities involves a high degree of risk. See &ldquo;Risk Factors&rdquo; beginning on page 6 in this prospectus for a
discussion of information that should be considered in connection with an investment in our securities.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed
upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
date of this prospectus is July 23, 2021.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TABLE
OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_001">ABOUT THIS PROSPECTUS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.5in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii
    </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><A HREF="#SSS_001"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAUTIONARY </FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">NOTE REGARDING FORWARD LOOKING STATEMENTS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_003">THE COMPANY</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_004">RISK FACTORS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_005">USE OF PROCEEDS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_006">SELLING STOCKHOLDERS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_007">LEGAL MATTERS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_008">EXPERTS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_009">WHERE YOU CAN FIND MORE INFORMATION; INCORPORATION BY REFERENCE</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_001"></A>ABOUT
THIS PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus is part of a registration statement on Form S-3 that we filed with the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;).
You should read this prospectus and the information and documents incorporated by reference carefully. Such documents contain important
information you should consider when making your investment decision. See &ldquo;Where You Can Find More Information&rdquo; and &ldquo;Incorporation
of Certain Information by Reference&rdquo; in this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus may be supplemented from time to time to add, to update or change information in this prospectus. Any statement contained
in this prospectus will be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained
in a prospectus supplement modifies or supersedes such statement. Any statement so modified will be deemed to constitute a part of this
prospectus only as so modified, and any statement so superseded will be deemed not to constitute a part of this prospectus. You may only
rely on the information contained in this prospectus or that we have referred you to. We have not authorized anyone to provide you with
different information. This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities other
than the securities offered by this prospectus. This prospectus and any future prospectus supplement do not constitute an offer to sell
or a solicitation of an offer to buy any securities in any circumstances in which such offer or solicitation is unlawful. Neither the
delivery of this prospectus or any prospectus supplement nor any sale made hereunder shall, under any circumstances, create any implication
that there has been no change in our affairs since the date of this prospectus or such prospectus supplement or that the information
contained by reference to this prospectus or any prospectus supplement is correct as of any time after its date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the
actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some
of the documents referred to herein have been filed, will be filed or will be incorporated by reference as exhibits to the registration
statement of which this prospectus is a part, and you may obtain copies of those documents as described below under &ldquo;Where You
Can Find More Information.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholder are offering the Shares only in jurisdictions where such offer is permitted. The distribution of this prospectus
and the sale of the Shares in certain jurisdictions may be restricted by law. Persons outside the United States who come into possession
of this prospectus must inform themselves about, and observe any restrictions relating to, the distribution of this prospectus and the
sale of the Shares outside the United States. This prospectus does not constitute, and may not be used in connection with, an offer to
sell, or a solicitation of an offer to buy, the Shares by any person in any jurisdiction in which it is unlawful for such person to make
such an offer or solicitation. If there is any inconsistency between the information in this prospectus and the applicable prospectus
supplement, you should rely on the prospectus supplement. Before purchasing any securities, you should carefully read both this prospectus
and the applicable prospectus supplement, together with the additional information described under the heading &ldquo;Where You Can Find
More Information; Incorporation by Reference.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not authorized any other person to provide you with different information. If anyone provides you with different or inconsistent
information, you should not rely on it. We will not make an offer to sell these securities in any jurisdiction where the offer or sale
is not permitted. You should assume that the information appearing in this prospectus and the applicable prospectus supplement to this
prospectus is accurate as of the date on its respective cover, and that any information incorporated by reference is accurate only as
of the date of the document incorporated by reference, unless we indicate otherwise. Our business, financial condition, results of operations
and prospects may have changed since those dates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
we refer to &ldquo;LifeMD,&rdquo; &ldquo;we,&rdquo; &ldquo;our,&rdquo; &ldquo;us&rdquo; and the &ldquo;Company&rdquo; in this prospectus,
we mean LifeMD, Inc., unless otherwise specified. When we refer to &ldquo;you,&rdquo; we mean the holders of the applicable series of
securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="SSS_001"></A>CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus, the documents that we incorporate by reference and any free writing prospectuses that we may authorize for use in connection
with this offering contain &ldquo;forward-looking statements&rdquo; within the meaning of Section 27A of the Securities Act of 1933,
as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. These forward-looking
statements can generally be identified as such because the context of the statement will include words such as &ldquo;may,&rdquo; &ldquo;will,&rdquo;
&ldquo;intend,&rdquo; &ldquo;plan,&rdquo; &ldquo;believe,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;expect,&rdquo; &ldquo;estimate,&rdquo;
&ldquo;predict,&rdquo; &ldquo;potential,&rdquo; &ldquo;continue,&rdquo; &ldquo;likely,&rdquo; or &ldquo;opportunity,&rdquo; the negative
of these words or words of similar import. Similarly, statements that describe our future plans, strategies, intentions, expectations,
objectives, goals or prospects are also forward-looking statements. Discussions containing these forward-looking statements may be found,
among other places, in the &ldquo;Business&rdquo; and &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results
of Operations&rdquo; sections incorporated by reference from our most recent Annual Report on Form 10-K and our Quarterly Reports on
Form 10-Q for the quarterly periods ended subsequent to our filing of such Annual Report on Form 10-K, as well as any amendments thereto
reflected in subsequent filings with the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
forward-looking statements are based largely on our expectations and projections about future events and future trends affecting our
business, and are subject to risks and uncertainties that could cause actual results to differ materially from those anticipated in the
forward-looking statements. The risks and uncertainties include, among others, those noted in the &ldquo;Risk Factors&rdquo; section
of this prospectus and in any applicable prospectus supplement or free writing prospectus, and those included in the documents that we
incorporate by reference herein and therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could
have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in the market acceptance of our products;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">increased
    levels of competition;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in political, economic or regulatory conditions generally and in the markets in which we operate;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    relationships with our key customers;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to retain and attract senior management and other key employees;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to quickly and effectively respond to new technological developments;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to protect our trade secrets or other proprietary rights, operate without infringing upon the proprietary rights of others
    and prevent others from infringing on our proprietary rights;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to successfully commercialize our products on a large enough scale to generate profitable operations;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">business
    interruptions resulting from geo-political actions, including war, and terrorism or disease outbreaks (such as the recent outbreak
    of COVID-19, or the novel coronavirus);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to continue as a going concern;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    need to raise additional funds in the future;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to successfully implement our business plan;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">being
    able to scale our telehealth platform built to improve the experience and medical care provided to patients across the country;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">intellectual
    property claims brought by third parties; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    impact of any industry regulation.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, past financial and/or operating performance is not necessarily a reliable indicator of future performance, and you should not
use our historical performance to anticipate results or future period trends. We can give no assurances that any of the events anticipated
by the forward-looking statements will occur or, if any of them do, what impact they will have on our results of operations and financial
condition. Except as required by law, we undertake no obligation to publicly revise our forward-looking statements to reflect events
or circumstances that arise after the filing of this prospectus or any applicable prospectus supplement or free writing prospectus, or
documents incorporated by reference herein and therein, that include forward-looking statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><A NAME="a_002"></A>Prospectus
Summary</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>This
summary highlights certain information about us, this offering and information appearing elsewhere in this prospectus and in the
documents we incorporate by reference. This summary is not complete and does not contain all of the information that you should
consider before investing in our securities. To fully understand this offering and its consequences to you, you should read this
entire prospectus carefully, including the information referred to under the heading &ldquo;Risk Factors&rdquo; in this prospectus
beginning on page 6, the financial statements and other information incorporated by reference in this prospectus when making
an investment decision. This is only a summary and may not contain all the information that is important to you. You should
carefully read this prospectus, including the information incorporated by reference therein, and any other offering materials,
together with the additional information described under the heading &ldquo;Where You Can Find More
Information&rdquo;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_003"></A>The
Company</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
following is a summary of what we believe to be the most important aspects of our business and the offering of our securities under this
prospectus. We urge you to read this entire prospectus, including the more detailed consolidated financial statements, notes to the consolidated
financial statements and other information incorporated by reference from our other filings with the SEC or included in any applicable
prospectus supplement. Investing in our securities involves risks. Therefore, carefully consider the risk factors set forth in any prospectus
supplements and in our most recent annual and quarterly filings with the SEC, as well as other information in this prospectus and any
prospectus supplements and the documents incorporated by reference herein or therein, before purchasing our securities. Each of the risk
factors could adversely affect our business, operating results and financial condition, as well as adversely affect the value of an investment
in our securities.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Business
Overview and Strategy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LifeMD
is a direct-to-patient telehealth technology company that provides a smarter, cost-effective and convenient way for a provider&rsquo;s
patients to access healthcare. We believe the traditional model of visiting a doctor&rsquo;s office, receiving a physical prescription,
visiting a local pharmacy, and returning to see a doctor for follow up care or prescription refills is inefficient, costly to patients,
and discourages many patients from seeking much needed medical care. The U.S. healthcare system is undergoing a paradigm shift, thanks
to new technologies and the emergence of direct-to-patient healthcare. Direct-to-patient telemedicine technology companies, like our
company, connect consumers to licensed healthcare professionals for care across numerous indications, including concierge care, men&rsquo;s
sexual health and dermatology, among others.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
telemedicine platform helps patients access their licensed providers for diagnoses, virtual care, and prescription medications, often
delivered on a recurring basis. In addition to our telemedicine technology offerings, we sell nutritional supplements and other over-the-counter
products. Many of our products are available on a subscription or membership basis, where a patient can subscribe to receive regular
shipments of prescribed medications or products. This creates convenience and often discounted pricing opportunities for patients and
recurring revenue streams for us. Our customer acquisition strategy combines strategic brand-building media placements and direct response
advertising methods across highly scalable marketing channels (i.e., national TV, streaming TV, streaming audio, podcast, print, magazines,
online search, social media, and digital).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
inception, we have helped more than 300,000 customers and patients, providing them greater access to high-quality, convenient, and affordable
care in all 50 states. Our telemedicine technology revenue increased 208% in 2020 vs. the prior year. Total revenue from recurring subscriptions
is approximately 70%. In addition to our telehealth technology business, we own 85.6% of PDFSimpli, a rapidly growing SaaS platform for
converting, signing, editing and sharing PDF documents. This business has also seen 165% year over year growth, with recurring revenue
of 100%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
people can relate to the hassle and inconvenience of seeking medical care. We believe that telemedicine platforms like ours will fundamentally
shift how a provider&rsquo;s patients access healthcare in the U.S., by necessity and by preference. With the average wait time to see
a physician in the U.S. now at greater than 29 days, according to a 2018 Merritt Hawkins Survey, and the U.S. projected to have a significant
shortfall of licensed physicians by 2030, we believe the U.S. healthcare infrastructure must change to accommodate patients. Timely and
convenient access to healthcare and prescription medications is a critical factor in improving quality of care and patient outcomes.
Our mission is to radically change healthcare with our portfolio of direct-to-patient telemedicine technology brands that encompass on-demand
medical treatment, online pharmacy and over-the-counter products. We want our brands to be top-of-mind for consumers considering telehealth.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the United States, healthcare spending is currently $4.0 trillion and is expected to grow to $6.2 trillion by 2028, according to the
Centers for Medicare and Medicaid Services. Physician services and prescription medications account for approximately 30% of healthcare
spending, or over $1 trillion annually, and we believe that we have the infrastructure, medical expertise, and technical know-how to
shift a substantial portion of this market to an online, virtual format. Our telemedicine platforms are fast and convenient, and we believe
the adoption of our services has increased rapidly because of these features, including lower out-of-pocket costs for a provider&rsquo;s
patients and the satisfaction of a simple healthcare process. We believe the opportunities are immense and that we are well positioned
to capitalize on these large scale economic shifts in healthcare.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that brand innovation, customer acquisition and service excellence form the heart of our business. As is exemplified with our
first brand, Shapiro MD, we have built a full line of proprietary OTC products for male and female hair loss, FDA approved OTC minoxidil,
an FDA-cleared medical device, and now a personalized telemedicine platform offering that gives consumers access to virtual medical treatment
from their providers and, when appropriate, a full line of oral and topical prescription medications for hair loss. Our men&rsquo;s brand,
Rex MD, offers access to provider-based treatment through telehealth for men&rsquo;s health conditions, currently providing prescription
medications and OTC products for chronic conditions such as sexual health and hair loss. Rex MD has recently expanded its services to
provide access to primary care and will soon offer treatments for additional chronic indications present in men&rsquo;s health. We have
built a platform that allows us to efficiently aid the provision of telehealth and provide wellness product lines wherever we determine
there is a market need. Our platform is supported by a driven team of digital marketing and branding experts, data analysts, designers,
and engineers focused on building enduring brands.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Our
Brand Portfolio</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have built a strategic portfolio of wholly-owned telemedicine platform brands that address large unmet needs in men&rsquo;s health, hair
loss and dermatology. LifeMD is also preparing to offer administrative support to various professional entities that will provide a direct
concierge medicine offering to patients under the LifeMD brand. We continue to scale our offerings in a calculated manner, ensuring that
each brand or indication we launch will enhance current and future patients&rsquo; experiences with our platform.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
process across each brand and condition that we treat is to guide the provider&rsquo;s patient through an intake process and product
selection, after which a licensed U.S. physician within our contracted network conducts a virtual consultation and, if appropriate, prescribes
necessary prescription medications and/or recommends over-the-counter products. Prescription and over the counter products are filled
by pharmacy fulfillment partners and shipped directly to the patient. The number of patients and customers we serve across the nation
continues to increase at a robust pace, with more than 300,000 individuals having purchased our products and services to date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hair
Loss: Shapiro MD</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Launched
in 2017, Shapiro MD offers access to virtual medical treatment, prescription medications, patented over-the-counter products, and an
FDA approved medical device for male and female hair loss through our telemedicine platform. Shapiro MD has emerged as a leading destination
for hair loss treatment across the U.S. and has had more than 200,000 customers and patients since inception. In Q1 2021, Shapiro MD
greatly enhanced its offerings for female hair loss treatment with the addition of topical compounded medications to its product portfolio.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 21, 2020, ConsumersAdvocate.org ranked ShapiroMD as the third best hair loss treatment provider in the United States, ahead
of other household brands such as Bosley, Keeps and Rogaine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Men&rsquo;s
Health: Rex MD</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Launched
in 2019, Rex MD is a men&rsquo;s telehealth platform brand offering access to virtual medical treatment from licensed providers for a
variety of men&rsquo;s health needs. After consultation with a physician, if appropriate, we dispense and ship prescription medications
and over-the-counter products directly to a provider&rsquo;s patients. Since our initial launch in the erectile dysfunction treatment
market, we have expanded our offerings to cover categories such as sexual health and hair loss in the first quarter of 2021. We intend
to continue expanding our offerings to cover many other chronic indications present in the men&rsquo;s health market. Our vision for
Rex MD is to become a leading telehealth destination for men.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dermatology:
Nava MD</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Launching
in the first quarter of 2021, Nava MD is a female-oriented tele-dermatology and skincare brand that will offer access to virtual medical
treatment from dermatologists and other providers, and, if appropriate, prescription oral and compounded topical medications to treat
many common dermatological conditions. In addition to the brand&rsquo;s telemedicine platform offerings, Nava MD&rsquo;s proprietary
products leverage intellectual property and proprietary formulations licensed from Restorsea, a leading medical grade skincare technology
platform.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restorsea&rsquo;s
clinically proven skincare technology platform is the result of more than $50 million invested in R&amp;D and intellectual property development
and has received 35 patents along with broad industry and academic acclaim, with its breakthrough clinical results having been published
in the peer-reviewed Journal of Drugs in Dermatology and Journal of Clinical and Aesthetic Dermatology. Nava MD will be one of the first
direct-to-consumer product lines to offer this advanced skincare technology. Nava MD will be positioned as an online skincare and telehealth
platform brand that will offer access to tele-dermatology services to a provider&rsquo;s patients in 47 states.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Immune
Health: iNR Wellness MD</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Launched
in 2018, iNR Wellness MD is a supplement for immune and digestive support. The iNR Wellness product line is a daily nutritional supplement
that contains yeast, oat, and mushroom beta glucans.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Majority
Owned Subsidiary: PDFSimpli</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PDFSimpli
is an online software-as-a-service (SAAS) platform that allows users to create, edit, convert, sign and share PDF documents. PDFSimpli
was acquired through the purchase of 51% of the membership interests of LegalSimpli Software, LLC, a Puerto Rico limited liability company,
which operates a marketing-driven software solutions business. As of December 30, 2020, PDFSimpli was ranked in the top 4,339 websites
globally, in which it was also ranked in the top 1,200 for specific countries with more than 9.5 million registrants globally. Since
its launch, PDFSimpli has converted or edited over 9 terabytes of documents for customers from the legal, financial, real-estate and
academic sectors. PDFSimpli had over 62,600 active subscriptions as of December 30, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Customers</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
customer base includes men and women seeking hair loss treatment and men&rsquo;s health issues. In 2021, we expect to broaden this customer
base to also include skincare and dermatology products for men and women. LifeMD is also preparing to offer administrative support to
various professional entities that will provide a direct concierge medicine offering to patients under the LifeMD brand. No single customer
accounted for more than 10% of net sales for the years ended December 31, 2020 and 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporate
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LifeMD,
Inc. was formed in the State of Delaware on June 21, 1994, under its prior name, Immudyne, Inc. The Company changed its name to Conversion
Labs, Inc. on June 15, 2018 and then subsequently, on February 18, 2021, it changed its name to LifeMD, Inc. Effective February 22, 2021,
the trading symbol for the Company&rsquo;s common stock, par value $0.01 per share on The Nasdaq Stock Market LLC changed from &ldquo;CVLB&rdquo;
to &ldquo;LFMD&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 1, 2016, the original operating agreement of Immudyne PR LLC (&ldquo;Immudyne PR&rdquo;), a joint venture to market the Company&rsquo;s
skincare products, was amended and restated and the Company increased its ownership and voting interest in Immudyne PR to 78.2%. Concurrent
with the name change of the parent company to Conversion Labs, Inc., Immudyne PR was renamed to Conversion Labs PR LLC. On April 25,
2019, the operating agreement of Conversion Labs PR was amended and restated in its entirety to increase the Company&rsquo;s ownership
and voting interest in Conversion Labs PR to 100%. On February 22, 2021, concurrent with the name of the parent company to LifeMD, Inc.,
Conversion Labs PR LLC was renamed to LifeMD PR, LLC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Recent
Developments</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>Appointment
of President</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 10, 2021 (the &ldquo;Effective Date&rdquo;), the Board appointed Mr. Alexander Mironov as the Company&rsquo;s President (the &ldquo;Appointment&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Mironov, age 41, brings a wealth of knowledge from his over 20 years of experience leading business development, mergers, and acquisitions,
as well as corporate strategy in the pharmaceutical space, most recently at Covis Pharma, a global private pharmaceutical company backed
by Apollo Global Management, Inc., an investment manager with nearly half a trillion of total assets under management. Over his career,
Mr. Mironov has led transactions in the pharmaceutical space totaling over $5 billion in value including M&amp;A, licensing, and equity
and debt financings. At Covis, he served as Chief Business Officer from 2016 to 2021, leading global business development and M&amp;A,
corporate strategy, and life-cycle management, and taking responsibility for over half a dozen transformational transactions, which significantly
contributed to the accelerated growth and expansion of Covis to over 50 global markets and new therapeutic segments. His contributions
at Covis directly led to revenues increasing over 10x during his tenure. Prior to Covis, Mr. Mironov held similar roles focusing on a
buy and build strategy at Alvogen, Pernix Pharma, Esprit Pharma, EKR Therapeutics, and Valera Pharma.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Appointment, Mr. Mironov entered into an Employment Agreement (the &ldquo;Employment Agreement&rdquo;) with the Company.
The Employment Agreement is for an indefinite term and may be terminated with or without cause. Pursuant to the Employment Agreement,
Mr. Mironov will receive an annual base salary of $500,000.00 and shall be eligible to earn a performance bonus in such amount, if any,
as determined in the sole discretion of the Board, with a target amount of 20% of the base salary. To induce Mr. Mironov to enter into
the Employment Agreement, he was granted a performance-based grant of up to 300,000 restricted shares of the Company&rsquo;s common stock
(the &ldquo;Restricted Shares&rdquo;), subject to, <I>inter alia</I>, his sourcing, and material contribution to, the consummation of
pharmaceutical deals, as set forth in more detail in the Employment Agreement. As a further inducement to enter into the Employment Agreement,
Mr. Mironov received stock options (the &ldquo;Stock Options&rdquo;) to purchase up to 200,000 shares of the Company&rsquo;s common stock.
The Stock Options have a term of five years and shall vest in equal monthly tranches, based on the passage of time, over the 36 months,
beginning on the Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
termination of Mr. Mironov without cause, or upon his resignation for good reason, the Company shall pay or provide to Mr. Mironov severance
pay equal to his then current monthly base salary for twelve months from the date of termination, during which time Mr. Mironov shall
continue to receive all employee benefits and employee benefit plans as described in the Employment Agreement. As a full-time employee
of the Company, Mr. Mironov will be eligible to participate in all of the Company&rsquo;s benefit programs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>June
2021 Securities Purchase Agreement</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 1, 2021, we entered into a securities purchase agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;) with BRF Finance Co., LLC(the
&ldquo;<U>BRF</U>&rdquo;), pursuant to which the Company sold and issued: (i) a senior secured redeemable debenture (<U>the </U>&ldquo;<U>Debenture</U>&rdquo;)
in the aggregate principal amount of $15,000,000.00 (the &ldquo;<U>Aggregate Principal Amount</U>&rdquo;), and (ii) warrants to purchase
up to an aggregate of 1,500,000 shares of the Company&rsquo;s common stock at an exercise price of $12.00 per share (the &ldquo;<U>Warrant</U>&rdquo;).
However, the amount of shares exercisable pursuant to the Warrant is directly connected to how long the Debenture remains outstanding.
If the Debenture is repaid on or before the one year anniversary date of the Initial Exercise Date (as defined herein), BRF shall be
entitled to exercise up to 500,000 shares of common stock. Thereafter so long as the Debenture has not been repaid, beginning on the
date that is 366 days from the Initial Exercise Date, the Warrant may be exercised for up to an additional 500,000 shares of common stock.
Should the Debenture remain outstanding, beginning on the date that is 732 days from the Initial Exercise Date, the Warrant may be exercised
for up to an additional further 500,000 shares of common stock. The Warrant is immediately exercisable upon issuance (the &ldquo;<U>Initial
Exercise Date</U>&rdquo;) at an exercise price of $12.00 per share, subject to adjustment as provided therein. The Warrant has a term
of three years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to limited exceptions, BRF will not have the right to exercise any portion of the Warrant if BRF, together with its affiliates, would
exceed the Beneficial Ownership Limitation; provided, however, that upon 61 days&rsquo; prior notice to us, the holder may increase the
Beneficial Ownership Limitation, provided that in no event will the Beneficial Ownership Limitation exceed 9.99%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
received gross proceeds of $15,000,000 and intend to use such proceeds for working capital and general corporate purposes. The Purchase
Agreement contains customary representations, warranties and agreements by us and customary conditions to closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Debenture was assigned from BRF to B. Riley Principal Investments, LLC (hereinafter referred to as &ldquo;B. Riley&rdquo; or &ldquo;Holder&rdquo;)
on June 22, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Aggregate Principal Amount of the Debenture, together with interest, shall be due and payable on June 1, 2024. The Debenture bears interest
as follows as follows: (i) for the period beginning on June 1, 2021 and ending on the date that is six (6) months thereafter (the &ldquo;<U>Initial
Interest Rate Period</U>&rdquo;) shall be six percent (6%), (ii) for the period beginning the date following the Initial Interest Rate
Period and ending on the date that is three (3) months thereafter (the &ldquo;<U>Second Interest Rate Period</U>&rdquo;), nine percent
(9%), and (iii) for the period beginning the date following the Second Interest Rate Period and ending on June 1, 2024, twelve percent
(12%). The Debenture contains redemption provisions which require the Company to redeem the principal amount outstanding on the Debenture,
as set forth in the Debenture. Until such time as the Debenture shall have been paid in full, the Company shall apply thirty-five
percent (35%) of the gross proceeds received by the Company from At-The-Market offerings of its common stock to partial redemptions of
the Debenture.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Purchase Agreement, the Company has agreed to secure all of the Company&rsquo;s Obligations (as defined in the Purchase
Agreement) to the Purchaser under the Debenture, Company Security Agreement (as defined below) and all other Transaction Documents (as
defined in the Purchase Agreement) by granting to the Purchaser an unconditional and continuing security interest in all of the assets
and properties of the Company, whether now existing or hereafter acquired, pursuant to that certain Security Agreement, dated as of June
1, 2021 (the &ldquo;<U>Company Security Agreement</U>&rdquo;). Moreover, the subsidiaries of the Company, LifeMD PR, LLC, a limited liability
company organized and existing under the laws of Puerto Rico, and LegalSimpli Software, LLC, a limited liability company organized and
existing under the laws of Puerto Rico (each, a &ldquo;<U>Guarantor</U>&rdquo; and together, the &ldquo;<U>Guarantors</U>&rdquo;), have
agreed to deliver a guaranty agreement in favor of the Purchaser, dated as of June 1, 2021 (the &ldquo;<U>Guaranty Agreement</U>&rdquo;).
Furthermore, the Company entered into an Intellectual Property Security Agreement with the Holder dated as of June 1, 2021, granting
the Purchaser a security interest in certain intellectual property of the Company (&ldquo;<U>IP Security Agreement</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Purchase Agreement, the Company and the Purchaser also entered into a Registration Rights Agreement (the &ldquo;<U>Registration
Rights Agreement</U>&rdquo;) under which the Company agreed to register the shares underlying the Warrant within sixty (60) days (the
&ldquo;<U>Resale Registration Statement</U>&rdquo;), but in no event later than ninety (90) days following the filing deadline (the &ldquo;<U>Effectiveness
Deadline</U>&rdquo;); provided, that the Effectiveness Deadline shall be extended to one hundred twenty (120) days after the filing deadline
if the Resale Registration Statement is reviewed by, and receives comments from, the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Background of the Offering</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">See &ndash; &ldquo;<I>Recent
Developments- <U>June 2021 Securities Purchase Agreement</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
OFFERING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LifeMD,
    Inc.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    of Common Stock offered by us</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    of Common Stock offered by the Selling Stockholder</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,500,000
    Shares (1)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    of Common Stock outstanding before the Offering</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,665,840 </FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">shares
    (2)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    of Common Stock outstanding after completion of this offering, assuming the sale of all shares offered hereby</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,165,840
    </FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">shares</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use
    of proceeds</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    will receive proceeds from any warrants that are exercised through the payment of the exercise price in cash.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market
    for Common Stock</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    common stock is listed on The Nasdaq Capital Market under the symbol &ldquo;LFMD.&rdquo;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
    Factors</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing
    in our securities involves a high degree of risk. See the &ldquo;Risk Factors&rdquo; section of this prospectus on page 12 and in
    the documents we incorporate by reference in this prospectus for a discussion of factors you should consider carefully before deciding
    to invest in our securities.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10.5pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,500,000
shares of Common Stock underlying the Warrants, issued to the Selling Stockholder in the June 2021 Financing.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of shares of Common Stock outstanding before and after the Offering is based on 26,665,840 shares outstanding as of
    July 23, 2021 and excludes the following: </FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">4,113,400 <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
    of Common Stock issuable upon the exercise of outstanding stock options having a weighted average exercise price of $6.88
    per share;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,984,787
    </FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">shares of common stock issuable upon the exercise of outstanding
    warrants having a weighted average exercise price of $5.48 per share;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,076,923
</FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">shares of the Company&rsquo;s common stock upon conversion of the Company&rsquo;s
Series B Preferred Stock;&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="text-align: justify; margin: 0; font: 10pt Times New Roman, Times, Serif">659,375 shares
                                            of outstanding and exercisable Restricted Stock Units with a weighted-average exercise price
                                            of $12.47 per share; and</P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,131,750
    </FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">shares of common stock reserved for future issuance under the Company&rsquo;s
    2020 Equity and Incentive Plan (the &ldquo;2020 Plan&rdquo;)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_004"></A>RISK
FACTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business, financial condition, results of operations, and cash flows may be impacted by a number of factors, many of which are beyond
our control, including those set forth in our most recent Annual Report on Form 10-K for the year ended December 31, 2020, the occurrence
of any one of which could have a material adverse effect on our actual results. There have been no material changes to the Risk Factors
previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_005"></A>USE
OF PROCEEDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
proceeds from the resale of the shares of our Common Stock offered by this prospectus will belong to the Selling Stockholder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will receive proceeds from any cash exercise of the Warrants. If all such Warrants are fully exercised on a cash basis, we will receive
gross cash proceeds of approximately $12.00 per Warrant exercised. We expect to use the proceeds from the exercise of such warrants,
if any, for general corporate purposes. General corporate purposes may include providing working capital, funding capital expenditures,
or paying for acquisitions. We currently do not have any arrangements or agreements for any acquisitions. We cannot precisely estimate
the allocation of the net proceeds from any exercise of the warrants for cash. Accordingly, in the event the Warrants are exercised for
cash, our management will have broad discretion in the application of the net proceeds of such exercises. There is no assurance that
the Warrants will ever be exercised for cash.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PRIVATE
PLACEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 1, 2021, we entered into the Purchase Agreement with BRF, pursuant to which the Company sold and issued: (i) the Debenture Warrants
to BRF. However, the amount of shares exercisable pursuant to the Warrants is directly connected to how long the Debenture remains outstanding.
If the Debenture is repaid on or before the one year anniversary date of the Initial Exercise Date (as defined herein), the BRF shall
be entitled to exercise up to 500,000 shares of common stock. Thereafter so long as the Debenture has not been repaid, beginning on the
date that is 366 days from the Initial Exercise Date, the Warrant may be exercised for up to an additional 500,000 shares of common stock.
Should the Debenture remain outstanding, beginning on the date that is 732 days from the Initial Exercise Date, the Warrant may be exercised
for up to an additional further 500,000 shares of common stock. The Warrant is immediately exercisable upon issuance (the &ldquo;<U>Initial
Exercise Date</U>&rdquo;) at an exercise price of $12.00 per share, subject to adjustment as provided therein. The Warrant has a term
of three years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to limited exceptions, BRF will not have the right to exercise any portion of the Warrant if the BRF, together with its affiliates, would
exceed the Beneficial Ownership Limitation; provided, however, that upon 61 days&rsquo; prior notice to us, the holder may increase the
Beneficial Ownership Limitation, provided that in no event will the Beneficial Ownership Limitation exceed 9.99%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Debenture was assigned from BRF to B. Riley Principal Investments, LLC (hereinafter referred to as &ldquo;B. Riley&rdquo; or &ldquo;Holder&rdquo;)
on June 22, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Aggregate Principal Amount of the Debenture, together with interest, shall be due and payable on June 1, 2024. The Debenture bears interest
as follows as follows: (i) for the period beginning on June 1, 2021 and ending on the the Initial Interest Rate Period shall be six percent
(6%), (ii) for the period beginning the date following the Initial Interest Rate Period and ending on the date that is the Second Interest
Rate Period, nine percent (9%), and (iii) for the period beginning the date following the Second Interest Rate Period and ending on June
1, 2024, twelve percent (12%). The Debenture contains redemption provisions which require the Company to redeem the principal amount
outstanding on the Debenture, as set forth in the Debenture. Until such time as the Debenture shall have been paid in full, the Company
shall apply thirty-five percent (35%) of the gross proceeds received by the Company from At-The-Market offerings of its common stock
to partial redemptions of the Debenture.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Purchase Agreement, the Company has agreed to secure all of the Company&rsquo;s Obligations (as defined in the Purchase
Agreement) to the Purchaser under the Debenture, Company Security Agreement (as defined below) and all other Transaction Documents (as
defined in the Purchase Agreement) by granting to Holder an unconditional and continuing security interest in all of the assets and properties
of the Company, whether now existing or hereafter acquired, pursuant to the Company Security Agreement. Moreover, the subsidiaries of
the Company, each, a Guarantor, have agreed to deliver the Guaranty Agreement. Furthermore, the Company entered into the I.P Security
Agreement granting the Holder a security interest in certain intellectual property of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Purchase Agreement, the Company and the Holder also entered into a Registration Rights Agreement under which the
Company agreed to register the shares underlying the Warrant within sixty (60) days but in no event later than the Effectiveness Deadline;
provided, that the Effectiveness Deadline shall be extended to one hundred twenty (120) days after the filing deadline if the Resale
Registration Statement is reviewed by, and receives comments from, the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing descriptions of the Debenture, Warrant, Purchase Agreement, Registration Rights Agreement, Company Security Agreement, Guarantor
Security Agreement, Guarantee Agreement, and Intellectual Property Security Agreement are qualified in their entirety by reference to
the full text of the Form of Debenture, Form of Warrant, Form of Securities Purchase Agreement, Form of Registration Rights Agreement,
Form of Company Security Agreement, Form of Guarantor Security Agreement, Form of Guarantee Agreement, and Form of Intellectual Property
Security Agreement, which are attached to the Company&rsquo;s Current Report on Form 8-k filed with the SEC on June 1, 2021 as Exhibits
4.1, 4.2, 10.1, 10.2, 10.3, 10.4, 10.5, and 10.6 respectively, and incorporated herein by reference in their entirety.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_006"></A>SELLING
STOCKHOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of our Common Stock being offered by the Selling Stockholders are issuable upon the exercise of the Warrants. For additional information
regarding the issuance of Warrants, see &ldquo;Recent Developments&rdquo; - &ldquo;June 2021 Financing&rdquo; above. We are registering
the shares of our Common Stock in order to permit the Selling Stockholder to offer the shares for resale from time to time. Except as
otherwise described in the footnotes to the table below and for the ownership of the registered shares issued pursuant to the Purchase
Agreement, neither the Selling Stockholder nor any of the persons that control them has had any material relationships with us or our
affiliates within the past three (3) years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below lists the Selling Stockholder and other information regarding the beneficial ownership (as determined under Section 13(d)
of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;) (and the rules and regulations thereunder) of the
shares of our Common Stock held by the Selling Stockholder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
second column lists the number of shares of our Common Stock beneficially owned by each Selling Stockholder before this Offering (including
shares which the Selling Stockholder has the right to acquire within 60 days, including upon conversion of any convertible securities)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
third column lists the shares of our Common Stock being offered by this prospectus by each Selling Stockholder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fourth and fifth columns list the number of shares of Common Stock beneficially owned by each Selling Stockholder and their percentage
ownership after the Offering (including shares which the Selling Stockholder has the right to acquire within 60 days, including upon
conversion of any convertible securities), assuming the sale of all of the shares offered by each Selling Stockholder pursuant to this
prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the Warrants, a Selling Stockholder may not exercise the Warrants to the extent such conversion or exercise would cause
such Selling Stockholder, together with any other person with which the Selling Stockholder is considered to be part of a group under
Section 13 of the Exchange Act or with which the Selling Stockholder otherwise files reports under Section 13 and/or 16 of the Exchange
Act, to beneficially own a number of shares of Common Stock which exceeds 4.99% or 9.99%, as applicable, of the common stock that is
registered under the Exchange Act that is outstanding at such time. The number of shares in the third column does not reflect this limitation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amounts and information set forth below are based upon information provided to us by the Selling Stockholder as of July 23, 2021,
except as otherwise noted below. The Selling Stockholder may sell all or some of the shares of Common Stock it is offering, and may sell,
unless indicated otherwise in the footnotes below, shares of our common stock otherwise than pursuant to this prospectus. The tables
below assume the Selling Stockholder sells all of the shares offered by them in offerings pursuant to this prospectus, and do not acquire
any additional shares. We are unable to determine the exact number of shares that will actually be sold or when or if these sales will
occur.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Selling Stockholder</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of Shares Owned Before Offering(2)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares Offered<BR> Hereby</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number of Shares Owned</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>After Offering</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Percentage of</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Beneficially</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Owned After</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Offering(1)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: left">B. Riley Principal Investments, LLC</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">1,500,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">1,500,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">0</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Percentages
    are calculated based on an aggregate of 26,665,840 shares of Common Stock outstanding as of July 12, 2021. As applicable,
    such percentages have been further adjusted to account for outstanding convertible securities of such Selling Stockholder.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Represents
                                            up to 1,500,000 shares of common stock issuable upon exercise of the Warrants. The amount
                                            of shares exercisable pursuant to the Warrants is directly connected to how long the Debenture
                                            remains outstanding. If the Debenture is repaid on or before the one year anniversary date
                                            of the Initial Exercise Date (as defined herein), the Holder shall be entitled to exercise
                                            up to 500,000 shares of common stock. Thereafter so long as the Debenture has not been repaid,
                                            beginning on the date that is 366 days from the Initial Exercise Date, the Warrant may be
                                            exercised for up to an additional 500,000 shares of common stock. Should the Debenture remain
                                            outstanding, beginning on the date that is 732 days from the Initial Exercise Date, the Warrant
                                            may be exercised for up to an additional further 500,000 shares of common stock. These securities
                                            are owned directly by B. Riley Principal Investments, LLC, is an indirect wholly-owned subsidiary
                                            of B. Riley Financial, Inc.&nbsp; B. Riley Principal Investments, LLC has voting and investment
                                            discretion over these securities.&nbsp; Daniel Shribman in his capacity as the President
                                            of B. Riley Principal Investments, LLC makes voting and investment decisions on behalf of
                                            B. Riley Principal Investments, LLC.</P>

</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_007"></A>LEGAL
MATTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lucosky
Brookman LLP will pass upon certain legal matters relating to the issuance and sale of the securities offered hereby on behalf of LifeMD,
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_008"></A>EXPERTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Friedman
LLP, an independent registered public accounting firm, has audited our consolidated balance sheet as of December 31, 2020, and the related
consolidated statements of operations, stockholders&rsquo; deficit, and cash flows for the fiscal years ended December 31, 2020, which
report is incorporated by reference in this prospectus. We have incorporated by reference our financial statements in this prospectus
and in this registration statement in reliance on the report of Friedman LLP given on their authority as experts in accounting and auditing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BF
Borgers CPA PC, an independent registered public accounting firm, has audited our consolidated balance sheet as of December 31, 2019,
and the related consolidated statements of operations, stockholders&rsquo; deficit, and cash flows for the fiscal years ended December
31, 2019, which report is incorporated by reference in this prospectus. We have incorporated by reference our financial statements in
this prospectus and in this registration statement in reliance on the report of BF Borgers CPA PC given on their authority as experts
in accounting and auditing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_009"></A>WHERE
YOU CAN FIND MORE INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Available
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
file reports, proxy statements and other information with the SEC. Information filed with the SEC by us can be inspected and copied at
the Public Reference Room maintained by the SEC at 100 F Street, N.E., Washington, D.C. 20549. You may also obtain copies of this information
by mail from the Public Reference Room of the SEC at prescribed rates. Further information on the operation of the SEC&rsquo;s Public
Reference Room in Washington, D.C. can be obtained by calling the SEC at 1-800-SEC-0330. The SEC also maintains a web site that contains
reports, proxy and information statements and other information about issuers, such as us, who file electronically with the SEC. The
address of that website is <I>http://www.sec.gov</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
website address is https://lifemd.com. The information on our website, however, is not, and should not be deemed to be, a part of this
prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus and any prospectus supplement are part of a registration statement that we filed with the SEC and do not contain all of the
information in the registration statement. The full registration statement may be obtained from the SEC or us, as provided below. Forms
of the documents establishing the terms of the offered securities are or may be filed as exhibits to the registration statement. Statements
in this prospectus or any prospectus supplement about these documents are summaries and each statement is qualified in all respects by
reference to the document to which it refers. You should refer to the actual documents for a more complete description of the relevant
matters. You may inspect a copy of the registration statement at the SEC&rsquo;s Public Reference Room in Washington, D.C. or through
the SEC&rsquo;s website, as provided above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INCORPORATION
BY REFERENCE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC&rsquo;s rules allow us to &ldquo;incorporate by reference&rdquo; information into this prospectus, which means that we can disclose
important information to you by referring you to another document filed separately with the SEC. The information incorporated by reference
is deemed to be part of this prospectus, and subsequent information that we file with the SEC will automatically update and supersede
that information. Any statement contained in a previously filed document incorporated by reference will be deemed to be modified or superseded
for purposes of this prospectus to the extent that a statement contained in this prospectus modifies or replaces that statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
incorporate by reference our documents listed below and any future filings made by us with the SEC under Sections 13(a), 13(c), 14 or
15(d) of the Securities Exchange Act of 1934, as amended, which we refer to as the &ldquo;Exchange Act&rdquo; in this prospectus, between
the date of this prospectus and the termination of the offering of the securities described in this prospectus. We are not, however,
incorporating by reference any documents or portions thereof, whether specifically listed below or filed in the future, that are not
deemed &ldquo;filed&rdquo; with the SEC, including any information furnished pursuant to Items 2.02 or 7.01 of Form 8-K or related exhibits
furnished pursuant to Item 9.01 of Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus and any accompanying prospectus supplement incorporate by reference the documents set forth below that have previously been
filed with the SEC:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    Annual Report on <A HREF="https://www.sec.gov/Archives/edgar/data/948320/000149315221007194/form10-k.htm" STYLE="-sec-extract: exhibit">Form 10-K</A> for the year ended December 31, 2020, filed with the SEC on March 30, 2021.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    Quarterly Report on <A HREF="https://www.sec.gov/Archives/edgar/data/948320/000149315221011449/form10-q.htm" STYLE="-sec-extract: exhibit">Form 10-Q</A> for the quarter ended March 31, 2021, filed with the SEC on May 14, 2021. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    Current Reports on Form 8-K filed with the SEC <A HREF="https://www.sec.gov/Archives/edgar/data/948320/000149315221017563/form8-k.htm" STYLE="-sec-extract: exhibit">July 22, 2021</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/948320/000149315221016951/form8-k.htm" STYLE="-sec-extract: exhibit">July 15, 2021</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/948320/000149315221016109/form8-k.htm" STYLE="-sec-extract: exhibit">July
    2, 2021</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/948320/000149315221015594/form8-k.htm" STYLE="-sec-extract: exhibit">June
    29, 2021</A> <A HREF="https://www.sec.gov/Archives/edgar/data/948320/000149315221014801/form8-k.htm" STYLE="-sec-extract: exhibit">June
    21, 2021</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/948320/000149315221014560/form8-k.htm" STYLE="-sec-extract: exhibit">June
    16, 2021</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/948320/000149315221013492/form8-k.htm" STYLE="-sec-extract: exhibit">June
    3, 2021</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/948320/000149315221013322/form8-k.htm" STYLE="-sec-extract: exhibit">June
    1, 2021</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/948320/000149315221012202/form8-k.htm" STYLE="-sec-extract: exhibit">May
    19, 2021</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/948320/000149315221011307/form8-k.htm" STYLE="-sec-extract: exhibit">May
    13, 2021</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/948320/000149315221009159/form8-k.htm" STYLE="-sec-extract: exhibit">April
    19, 2021</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/948320/000149315221009046/form8-k.htm" STYLE="-sec-extract: exhibit">April
    16, 2021</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/948320/000149315221008952/form8-k.htm" STYLE="-sec-extract: exhibit">April
    15, 2021</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/948320/000149315221008118/form8-k.htm" STYLE="-sec-extract: exhibit">April
    6, 2021</A>, and <A HREF="https://www.sec.gov/Archives/edgar/data/948320/000149315221007652/form8-k.htm" STYLE="-sec-extract: exhibit">April
    1, 2021</A>.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
description of the Company&rsquo;s Common Stock contained in the Company&rsquo; Registration Statement on <A HREF="https://www.sec.gov/Archives/edgar/data/948320/000149315220023180/form8a-12b.htm" STYLE="-sec-extract: exhibit">Form 8-A</A> (File No. 001-39785)
filed on December 9, 2020, including any amendment or report filed for the purpose of updating such description.</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
reports and other documents we subsequently file pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act prior to the termination
of this Offering, including all such documents we may file with the SEC after the date of the initial registration statement and prior
to the effectiveness of the registration statement, but excluding any information furnished to, rather than filed with, the SEC, will
also be incorporated by reference into this prospectus and deemed to be part of this prospectus from the date of the filing of such reports
and documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Rule 412 under the Securities Act, any statement contained in the documents incorporated or deemed to be incorporated by reference
in this Registration Statement shall be deemed to be modified, superseded or replaced for purposes of this Registration Statement to
the extent that a statement contained herein or in any other subsequently filed document which also is incorporated or deemed to be incorporated
by reference in this Registration Statement modifies, supersedes or replaces such statement. Any such statement so modified, superseded
or replaced shall not be deemed, except as so modified, superseded or replaced, to constitute a part of this Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
written or oral request made to us at the address or telephone number below, we will, at no cost to the requester, provide to each person,
including any beneficial owner, to whom this prospectus is delivered, a copy of any or all of the information that has been incorporated
by reference into this prospectus (other than an exhibit to a filing, unless that exhibit is specifically incorporated by reference into
that filing), but not delivered with this prospectus:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LifeMD,
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">800
Third Avenue, Suite 2800</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(855)
743-6478</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PART
II</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INFORMATION
NOT REQUIRED IN PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
14. Other Expenses of Issuance and Distribution.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is an estimate of the expenses (all of which are to be paid by the registrant) that we may incur in connection with the securities
being registered hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 84%; text-align: left">SEC registration fee</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right"><P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">1590.68</P></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Legal fees and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">*</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Accounting fees and expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">*</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt">Total</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">*</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
15. Indemnification of Directors and Officers.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
102(b)(7) of the Delaware General Corporation Law permits a corporation to provide in its certificate of incorporation that a director
of the corporation shall not be personally liable to the corporation or its shareholders for monetary damages for breach of fiduciary
duty as a director, except for liability (i) for any breach of the director&rsquo;s duty of loyalty to the corporation or its shareholders,
(ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) for unlawful
payments of dividends or unlawful stock repurchases, redemptions or other distributions, or (iv) for any transaction from which the director
derived an improper personal benefit. Our amended certificate of incorporation provides that, to the maximum extent permitted by law,
no director shall be personally liable to us or our shareholders for monetary damages for breach of fiduciary duty as director.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
145 of the Delaware General Corporation Law provides that a corporation may indemnify directors and officers as well as other employees
and individuals against expenses (including attorneys&rsquo; fees), judgments, fines and amounts paid in settlement actually and reasonably
incurred by such person in connection with any threatened, pending or completed actions, suits or proceedings in which such person is
made a party by reason of such person being or having been a director, officer, employee or agent to the corporation. The Delaware General
Corporation Law provides that Section 145 is not exclusive of other rights to which those seeking indemnification may be entitled under
any bylaw, agreement, vote of shareholders or disinterested directors or otherwise. Our bylaws provide for indemnification by us of our
directors, officers and employees to the fullest extent permitted by the Delaware General Corporation Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
as indemnification for liabilities arising under the Securities Act may be provided for directors, officers, employees, agents or persons
controlling an issuer pursuant to the foregoing provisions, the opinion of the SEC is that such indemnification is against public policy
as expressed in the Securities Act, and is therefore unenforceable. In the event that a claim for indemnification by such director, officer
or controlling person of us in the successful defense of any action, suit or proceeding is asserted by such director, officer or controlling
person in connection with the securities being offered, we will, unless in the opinion of our counsel the matter has been settled by
controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by us is against public
policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
pending material litigation or proceeding involving our directors, executive officers, employees or other agents as to which indemnification
is being sought exists, and we are not aware of any pending or threatened material litigation that may result in claims for indemnification
by any of our directors or executive officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
16. Exhibits.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<I>Exhibits</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
list of exhibits filed with this registration statement on Form S-3 is set forth on the Exhibit Index and is incorporated herein by reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
17. Undertakings.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned registrant hereby undertakes:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent
    post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set
    forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if
    the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end
    of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b)
    if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering
    price set forth in the &ldquo;Calculation of Registration Fee&rdquo; table in the effective registration statement; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    include any material information with respect to the plan of distribution not previously disclosed in the registration statement
    or any material change to such information in the registration statement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
    for the purpose of determining any liability under the Securities Act of 1933 each such post-effective amendment shall be deemed
    to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall
    be deemed to be the initial bona fide offering thereof.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
    termination of the offering.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
    for the purpose of determining liability under the Securities Act of 1933 to any purchaser, each prospectus filed pursuant to Rule
    424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other
    than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of
    the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus
    that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration
    statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior
    to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the
    registration statement or made in any such document immediately prior to such date of first use.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
    for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution
    of the securities:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration
    statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold
    to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and
    will be considered to offer or sell such securities to such purchaser:</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule
    424;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by
    the undersigned registrant;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant
    or its securities provided by or on behalf of the undersigned registrant; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    undersigned Registrant hereby undertakes to provide to the underwriters at the closing specified in the underwriting agreement certificates
    in such denominations and registered in such names as required by the underwriters to permit prompt delivery to each purchaser.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
    as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons
    of the Registrant pursuant to the provisions described in Item 14 above, or otherwise, the Registrant has been advised that in the
    opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.
    In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred
    or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding)
    is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will,
    unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction
    the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed
    by the final adjudication of such issue.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    undersigned Registrant hereby undertakes:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
    for purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as
    part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the Registrant pursuant
    to Rule 424(b)(1) or (4), or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the
    time it was declared effective.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
    for the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus
    shall be deemed to be a new registration statement relating to the securities offered therein, and this offering of such securities
    at that time shall be deemed to be the initial bona fide offering thereof.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that
it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by
the undersigned, thereunto duly authorized, in the City of New York, State of New York, on July 23, 2021.</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">LifeMD, Inc.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Justin Schreiber</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Justin Schreiber<BR> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Chief Executive Officer and Director<BR>
(Principal Executive Officer)</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="pa_001"></A>POWER
OF ATTORNEY: KNOW ALL PERSONS BY THESE PRESENTS that each individual whose signature appears below constitutes and appoints Justin Schreiber,
his true and lawful attorneys-in-fact and agents with full power of substitution, for him and in his name, place and stead, in any and
all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to sign any
registration statement for the same offering covered by the Registration Statement that is to be effective upon filing pursuant to Rule
462(b) promulgated under the Securities Act, and all post-effective amendments thereto, and to file the same, with all exhibits thereto
and all documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents,
and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about
the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that
said attorneys-in-fact and agents or any of them, or his, her or their substitute or substitutes, may lawfully do or cause to be done
or by virtue hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities
and on the dates indicated:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 38%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 42%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 16%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Justin Schreiber</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    23, 2021</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Justin
    Schreiber</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer), Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Marc Benathen</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    23, 2021</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marc
    Benathen</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Financial and Accounting Officer)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Stefan Galluppi</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"> Chief
                                            Technology Officer, Director </P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    23, 2021</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stefan
    Galluppi </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    John R. Strawn Jr.</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    23, 2021</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">John
    R. Strawn Jr.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Roberto Simon</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    23, 2021</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Roberto
    Simon</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Joseph DiTrolio</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    23, 2021</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph
    DiTrolio</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Dr. Eleanor C. Mariano</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    23, 2021</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Eleanor C. Mariano</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Happy Walters</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    23, 2021</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Happy
    Walters</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>/s/
                                            Bertand Velge</I></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    23, 2021</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bertand
    Velge</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
INDEX</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    No.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    Description</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315221013492/ex4-1.htm" STYLE="-sec-extract: exhibit">Form of Debenture (incorporated herein by reference to Exhibit 4.1 of the Company&rsquo;s Form 8-K filed with the SEC on June 1, 2021)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315221013492/ex4-2.htm" STYLE="-sec-extract: exhibit">Form of Warrant (incorporated herein by reference to Exhibit 4.2 of the Company&rsquo;s Form 8-K filed with the SEC on June 1, 2021)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex5-1.htm">Opinion of Lucosky Brookman LLP</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/948320/000149315221013492/ex10-1.htm" STYLE="-sec-extract: exhibit">Form of Securities Purchase Agreement dated June 1, 2021 (incorporated herein by reference to Exhibit 10.1 of the Company&rsquo;s Form 8-Kfiled with the SEC on June 1, 2021)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/948320/000149315221013492/ex10-2.htm" STYLE="-sec-extract: exhibit">Form of Registration Rights Agreement (incorporated herein by reference to Exhibit 10.2 of the Company&rsquo;s Form 8-Kfiled with the SEC on June 1, 2021)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/948320/000149315221013492/ex10-3.htm" STYLE="-sec-extract: exhibit">Form of Company Security Agreement (incorporated herein by reference to Exhibit 10.3 of the Company&rsquo;s Form 8-K filed with the SEC on June 1, 2021)</A> </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/948320/000149315221013492/ex10-4.htm" STYLE="-sec-extract: exhibit">Form of Guarantor Security Agreement (incorporated herein by reference to Exhibit 10.4 of the Company&rsquo;s Form 8-Kfiled with the SEC on June 1, 2021)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/948320/000149315221013492/ex10-5.htm" STYLE="-sec-extract: exhibit">Form of Guaranty Agreement (incorporated herein by reference to Exhibit 10.5 of the Company&rsquo;s Form 8-Kfiled with the SEC on June 1, 20215</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/948320/000149315221013492/ex10-6.htm" STYLE="-sec-extract: exhibit">Form of Intellectual Property Agreement Security Agreement (incorporated herein by reference to Exhibit 10.6 of the Company&rsquo;s Form 8-Kfiled with the SEC on June 1, 2021)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1
    *</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="ex23-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Friedman LLP</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="ex23-2.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of BF Borgers CPA PC</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.3
    *</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex5-1.htm">Consent of Lucosky Brookman LLP (reference is made to Exhibit 5.1)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1
    *</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="#pa_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power of Attorney (included on the signature page of this Registration Statement)</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
    herewith.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 21; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>









































</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>forms-3_001.jpg
<TEXT>
begin 644 forms-3_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  J ,L# 2(  A$! Q$!_\0
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FZ#+#G<2W5_\ /K7:@!5"J  !@ =J6BL9S<F>GA\-&A&RW>[/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>ex5-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
5.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font: 11pt Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex5-1_001.jpg" ALT="" STYLE="height: 55px; width: 223px"></FONT></TD>
    <TD ROWSPAN="7" STYLE="width: 50%; font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex5-1_002.jpg" ALT="" STYLE="height: 183px; width: 151px"></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    23, 2021</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LifeMD, Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1460 Broadway</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New York, NY 10036</FONT></P>
                                                          <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>
                                                          <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Re:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares
    to be registered on Form S-3</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have acted as counsel to you, LifeMD, Inc., a Delaware corporation, (the &ldquo;Company&rdquo;) in connection with the Company&rsquo;s
Registration Statement No. 333- on Form S-3 (the &ldquo;Registration Statement&rdquo;) filed with the Securities and Exchange Commission
(the &ldquo;Commission&rdquo;) pursuant to the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;) with respect to
1,500,000 shares of the Company&rsquo;s common stock, par value $0.01 per share (the &ldquo;Common Stock&rdquo;) issuable upon exercise
of warrants (the &ldquo;Warrants&rdquo;) that may be sold from time to time (the &ldquo;Warrant Shares&rdquo;). This opinion is being
furnished in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with this opinion, we have examined the originals or copies certified or otherwise identified to our satisfaction of the following:
(a) Certificate of Incorporation of the Company, as amended to date, (b) By-laws of the Company, as amended to date, and (c) the Registration
Statement and all exhibits thereto. In addition to the foregoing, we also have relied as to matters of fact upon the representations
made by the Company and its representatives and we have assumed the genuineness of all signatures, the authenticity of all documents
submitted to us as originals, and the conformity to original documents of all documents submitted to us certified or photostatic copies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
upon the foregoing and in reliance thereon, and subject to the qualifications, limitations, exceptions and assumptions set forth herein,
we are of the opinion that the Warrant Shares, when issued upon exercise of the Warrants against payment therefore as set forth in the
Registration Statement, will be validly issued, fully paid and non-assessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
opinion expressed herein is limited to the laws of the State of Delaware, including the Constitution of the State of Delaware, all applicable
provisions of the statutory provisions, and reported judicial decisions interpreting those laws. This opinion is limited to the laws
in effect as of the date the Registration Statement is declared effective by the Commission and is provided exclusively in connection
with the public offering contemplated by the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
opinion letter speaks only as of the date hereof and we assume no obligation to update or supplement this opinion letter if any applicable
laws change after the date of this opinion letter or if we become aware after the date of this opinion letter of any facts, whether existing
before or arising after the date hereof, that might change the opinions expressed above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
opinion letter is furnished in connection with the filing of the Registration Statement and may not be relied upon for any other purpose
without our prior written consent in each instance. Further, no portion of this letter may be quoted, circulated or referred to in any
other document for any other purpose without our prior written consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby consent to the filing of this opinion with the Commission as an exhibit to the Registration Statement and to the use of our name
as it appears in the Prospectus included in the Registration Statement. In giving such consent, we do not thereby admit that we come
within the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission
promulgated thereunder. This opinion is expressed as of the date hereof unless otherwise expressly stated, and we disclaim any undertaking
to advise you of any subsequent changes in the facts stated or assumed herein or of any subsequent changes in applicable laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    Truly Yours,</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Lucosky Brookman LLP</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lucosky
    Brookman LLP</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex5-1_001.jpg
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  W -\# 2(  A$! Q$!_\0
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ME+B*U\0Z69XW=)F>-MI_NF_82_:>_8@_:1^".C+^PA\0/AIXG^#_ ,,;#1_
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MIS]FJ7N1J25W+VW6"DW+2#TLKO<:E4BXTW*DK65W+5Q3M;ETLVEWT/A?P/\
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M)8S#.7UV3E*2N[>R;;M9I.75^5C[MVYGK3;]G42]FM$^6[<E;6^EM=#]O?\
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MXF>+%\/>'(77#"[\3>(IM*\/V*J0SWNIP*""P-?R"^ _V#OBY^V-_P $^_\
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25[)OK9:A97;LKO=VU?J^I__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ex5-1_002.jpg
<TEXT>
begin 644 ex5-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "W )<# 2(  A$! Q$!_\0
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MC?<>'K;Q-JGA?PC\/_"$.G>#K;Q+\5O#TRZ>UIJO[1GPR\41:;:_!"QMM?\
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K@FAL[:*6&,^83'%(D:O&A\Z;*(RJ?-DR/WC9**=O7[_ZT\@-"BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>6
<FILENAME>ex23-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="padding: 0; margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.1</B></FONT></P>

<P STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Consent
of Independent Registered Public Accounting Firm</B></FONT></P>

<P STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
consent to the incorporation by reference in this Registration Statement on Form S-3 of our report dated March 30, 2021, relating to
the consolidated financial statements of LifeMD, Inc. and subsidiaries appearing in the Annual Report on Form 10-K of LifeMD, Inc. for
the year ended December 31, 2020.</FONT></P>

<P STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also consent to the reference to our firm under the heading &ldquo;Experts&rdquo; in the Prospectus, which is part of this Registration
Statement.</FONT></P>

<P STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
Friedman LLP</I></FONT></P>

<P STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marlton,
New Jersey</FONT></P>

<P STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
23, 2021</FONT></P>

<P STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>7
<FILENAME>ex23-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby consent to the incorporation in this Registration Statement on Form S-3 of our report dated March 30, 2020, relating to the financial
statements of LifeMD, Inc. (Formerly Conversion Labs, Inc.) as of December 31, 2019 and to all references to our firm included in this
Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="ex23-2_001.jpg" ALT="" STYLE="height: 25.5pt; width: 122.25pt"></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certified
Public Accountants</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lakewood,
CO</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
23, 2021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ex23-2_001.jpg
<TEXT>
begin 644 ex23-2_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0#"17AI9@  24DJ  @    " #$! @ +
M    )@   &F'!  !    ,@        !0:6-A<V$@,RXP   %  *@!  !
M[!,   .@!  !    31D   "0!P $    ,#(Q, 6@!  !    E@   ""D @ A
M    =         !F.6%C8F0R8C,P,34R83-A9&8T9C<U,&4X,&,P-C9C-@
M @ !  ( !0   +0    "  < !    # Q,#      (" @(   _^T '%!H;W1O
M<VAO<" S+C  .$))300$        _]L 0P *!P<(!P8*" @("PH*"PX8$ X-
M#0X=%181&",?)20B'R(A)BLW+R8I-"DA(C!!,30Y.SX^/B4N1$E#/$@W/3X[
M_]L 0P$*"PL.#0X<$! <.R@B*#L[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[_\  $0@ 0@%  P$B  (1 0,1 ?_$
M !L  0 " P$!               !!0,$!@('_\0 -1   00"  0#!P,$ 04
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M*1BY.@W2+?[HN>>[+8BW5DLWQ<BLSMA?&6!O)OL6KH5LHX^MF*5A$104$1$
M1$0!$1 $1$ 1$0!$6G>RU#&@&Y:CB)[ GJ?L.JU)MTC&TMFXBPPVH+%9MF&9
MKX7-Y@\'IKU6C)Q)AHGEKLA!L=].W^%JC)Z0;2+-%C@L0VH6S5Y6RQN[.8=@
MJJS?$3,38AA;#XSG$.ET=>&PD#?]RD82DZ0<DE;+E$!V-CJ$4FA$6KDR\8NT
M8W.:\0NY2WN#I:E;HQND:EOB7%TK#H)+'-(W]P8TNU]^RL*EN"[7;8K2MEB?
MV<T]%6\.5H&8*NX1L+I6<TAUU<3WVL/#T?L5_*X]K>6&*<21- Z!KAM=90C3
M2VB%)]7ZEZ2 -DZ [JI=Q/B6VV56V?$D>X,'AL+AL_/LL%AK\YEI*8F>RE4T
M)FL.O%>?A)] K08ZF&0L;7C:V!W-&UHT&GU68QCYMBY/RFRI4(N1T*)\,;^-
MHWO +F4^9GR/-K\%9.+!O!2 =S(S7UY@IN,>.)8)HV!TGL<G*"= D$:'^557
M)LY+=K6,KC#[%7?SF.NX/]X=G'UTO7%7*,KTC@W2:.LCV&#F[ZZKTL-2W!=K
MML5Y!)&_L0LR\K33[.Z/$C0Z-S2-@@@A5?"X#>'ZS>8'EYAT\O>/16Y7*X;A
MNE/5?8>^R)'2R \DY &G$>2Z0IP=OV_)SE>2HZ@L:7!Q:"YO8D=0O2T<5C&X
MN!T3;$\_,[F+IG\Q6\N;J^BT%5//+Q5&-'3Z;NOT>/\ :M50Y6H+V?KP>/-"
M'59-NB=RG7,WIM7Q[?R)GH]Y9S;V7H8Z-W,8I?:)P/@:T=-^FR5=*B_I*G"S
MGJV+,-D=I_%)<3Y;]5M8*_/;I2,N<OM-61T,I'8D?%]PJFDXK%Z,BW?9:(JN
MQQ#CZ\_AN<][0X-?+'&71QD]N9W8*Q;+&]Y8U[2X#J 02%S<9+:+33T>T4%P
M:TN<0 .I)0$$ @[!4FDHH4[0!$1 $4*4 1$0&CE;KJ==K80'6)W".%I\W'^!
MW7G'XF&FTOD_Y[,G66>0;<X_P/DL3MS\3,:0"VO6)&_^YQU^%:+K)XQ27J0O
M$VV:KJ->#'S5H8FLC>U^V@=.H.U7<-T:0P%4BM$2^/WBY@)<=G>U<R[,3]'1
MY3U^RXG 8+(V:C)G3"!DG[9V2$OY#W#6]AOU5P\4';HF74E2+SAJ)D3\H8 !
M7-UXC:.PT!O7W6O+1;ELGFM@.U VNSY$>]^=*^JU8:59E>!@9&P: _E<QCLM
MD6BS)3PTUEUBP^3Q"0UFM\HZ^?9;%N3E*/[^T9*DDF7?#UDVL'5>_P#>UGAO
M^1;T*LER_"<F49/<IV8(HXH9W<PW[S2[KH>H74+GRJILN#N*"QV6\]65OJQP
M_P %9%YE($3R>@#3W^BYK9;./PPSL5>G-!"ZS6;#RQL$S6-V=[+@>I5[A,7/
M1-FU<E;)<N2<\O)^UNNS1] O/"KQ)P[4<#L$.[_^15NNW+-Y-4<H1Z3*;AI[
MI:]R9P_ZEN0CZ*Y5+PSRQ06Z>P)(;+^9OH">BNU/+YV5Q^5$(B+D65LP/]25
M3S#7LT@U]VJSTN<RV590XKQ['-YQ+$Z,AO=O,X:.O/LNC72:=1^1$=LHZL?Z
M7Q+)5CT*UR(RM8/@>.A_NKQ4<CQ<XLA;">84HG>*X=FEW8?57BWD]&]T(>H5
M9@!K'.Z[W/*?_LJS7.<*7;$SKM.2)K65I3IXWU+G.)'V613<'] WXD=&B;1<
MRPN<R^3CQG$M625CY&FJ]H9&WF<7%PT /L5T:Y[*8^]8XGJ6JH#1! 2'O;MF
M]GH?KM=>&LN_8Y\EUT93FLKT<WAZP6'UE;O^RIZF;K^#G7<W@SS$NCADZ.YN
M71'UVKYSLW8'A""K5!&C+XID(^8&AU^JEG#>+%2.O-59-R=2]X]YQ/<DA=5*
M$5VOL0U)OHY3%V[=GA:3&UJC@XAYGL2CW&M_DZ&E[@D@PGZ;>C86ODIO?+U.
MI'$=-_=63L3FJ,%K&T&125++CRRO?HQ!W?IYJRM<-5;<%.)\DC#5:& L^)OF
M#OUTNKY8)]Z9"A)KK:*JGE9[/"N4-V4OEBYF$GN.8=!_E9<1Q'!7P5.$MDLV
MQ&6F&(;< W?4^@UI:6>Q5QV5=3HV(W,ORB5\/+U;KS)]%O\ "M(0XZ_&0'3B
M9\9?YGIVWZ;22AAE]34Y94;$V=?D*M.+%^[8O-+@YW7P6CNX_P *OKY;)8W)
MVL4'/R4[I6B$R.T&]-DGT&EEX0Q4]:2Q9MQ.8]H$,8<W6AW.AZ=E85</+%Q-
M<R4G*8Y& 1:/7>AO\*'\.#E'T_)JRDE(S8C+&]3FDM-9!)7D<R73O=&O/9\E
MK/SMRZ2W#8\V&;UX\KN6/_:I+CG_ *KD,/%S-??N1D]->YK;EVD$,=>%D,30
MUC!IH'D%$XQAW6RHMRZLT\3!D8HGR9*R)9I""&-'NQCT"L$1>=NW9U2I!$18
M:4]=H9Q5;]X;DK1G7T)'^E;JHR^.N/N09'&N8+,0Y',D.FO8?)81)Q/.US3!
M3K'7[N?F/U\UW<5-)IHY)XVJ-IN4%RWD*441Y:K-.FWT+B.VECX4.^&Z9V?V
MGH3O74K+C<2,=CI8B\RSS<SYI#\;B%CX7AL5^'ZT5ECF2#FVUPT=<Q[K)8XO
M'W7Y-5VK-C-VG4L+<L-/*Z.%Q:?0ZT%XP$7A8"BTCKX+2?J1L_E>\W3EOX>Q
M4AY?$E;RCF.AW"VJT1@K11'1+&!IU\@IM85_97\BFIS,9QE>@C?S>) Q[P/A
M<-#\$*]6LW'U69!]]L0%B1G(Y^SU'T6TLG)2:H15$+S*WFB>W6]M(U]EZ\D4
M%%)PC#/7P,<%B)\;XWO&G[]?PKM$52EE)LQ*E13Y+$VO;FY+%R1Q6M<LC9 >
M60?/7FL?ZAQ$QFG86-[A\3+ T?LKQ%2Y.J:LG#OIE'BK^?FOB+(8QL,!;LRA
MP]TZ[=SO95XBE3)IO5%)44&5P5RUQ!5R=2>&,0LTX2-+MD'I^5N/J96R0V6_
M'7C\Q7C]X_\ L[LK-%7Q94E[$X*[-:E0K8^'P:T?(W>R>Y<?4GS*V410VV[9
M25!0UC6;Y6@;.SH=RI18:$1$ 1 B (B( A1$!3XQH?FLG-(!XK9&QM/F&:V%
MXX78WV&Q,#LS69'$^O72R9#&7C;DMXNQ%%+-'X<K96DM/HX:\PMW&46X['Q5
M6NY_#;U<1KF/F5WE)8]/=?X<HQ>7W-K2*5"X'4U3CJAOB^86^TAO*)/DMI$6
MMM[,I((B+#0B(@"(B (B( B(@"A2H0$HH4H H1$!*(B *$1 2GFB(!YHB( I
M1$!"E$0$(B( B(@ 1$0!$1 %*(@(1$0!$1 $1$!"E$0#R1$0$>BE$0!$1 0I
..1$ \T1$ 1$0!$1 ?_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
